158 related articles for article (PubMed ID: 18274744)
21. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy in primary breast cancer: trust the radiolabeled colloid method and avoid unnecessary procedures.
Schmid SM; Myrick ME; Forrer F; Obermann EC; Viehl CT; Rochlitz C; Güth U
Eur J Surg Oncol; 2011 Mar; 37(3):211-6. PubMed ID: 21251790
[TBL] [Abstract][Full Text] [Related]
23. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
[TBL] [Abstract][Full Text] [Related]
24. Indications and technique of sentinel lymph node biopsy in breast cancer using 99m-technetium labeled tin colloids.
Sato K; Uematsu M; Saito T; Ishikawa H; Yamasaki T; Tamaki K; Tamai S; Kusano S; Hiraide H; Mochizuki H
Breast Cancer; 2000 Jan; 7(1):95-8. PubMed ID: 11029779
[TBL] [Abstract][Full Text] [Related]
25. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches.
Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A
Tumori; 2013; 99(2):149-53. PubMed ID: 23748806
[TBL] [Abstract][Full Text] [Related]
27. Improved lymphatic mapping technique for breast cancer.
Beitsch PD; Clifford E; Whitworth P; Abarca A
Breast J; 2001; 7(4):219-23. PubMed ID: 11678798
[TBL] [Abstract][Full Text] [Related]
28. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
29. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.
McMasters KM; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Dirk Noyes R; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Edwards MJ
Ann Surg; 2000 May; 231(5):724-31. PubMed ID: 10767794
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
[TBL] [Abstract][Full Text] [Related]
31. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
Arcan P; Ibis E; Aras G; Cam R; Küçük NO
Clin Nucl Med; 2005 May; 30(5):317-21. PubMed ID: 15827399
[TBL] [Abstract][Full Text] [Related]
32. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer.
Abdollahi A; Jangjoo A; Dabbagh Kakhki VR; Rasoul Zakavi S; Memar B; Naser Forghani M; Mehrabibahar M; Sadeghi R
Rev Esp Med Nucl; 2010; 29(2):73-7. PubMed ID: 19931946
[TBL] [Abstract][Full Text] [Related]
33. Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.
Bassi KK; Seenu V; Ballehaninna UK; Parshad R; Chumber S; Dhar A; Gupta SD; Kumar R; Srivastava A
Indian J Cancer; 2006; 43(3):103-9. PubMed ID: 17065767
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.
Nwariaku FE; Euhus DM; Beitsch PD; Clifford E; Erdman W; Mathews D; Albores-Saavedra J; Leitch MA; Peters GN
Am J Surg; 1998 Dec; 176(6):529-31. PubMed ID: 9926784
[TBL] [Abstract][Full Text] [Related]
36. Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer.
Lynch MA; Jackson J; Kim JA; Leeming RA
Surgery; 2008 Oct; 144(4):525-31; discussion 531-2. PubMed ID: 18847635
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node detection in breast carcinoma.
Pelosi E; Arena V; Baudino B; Bellò M; Giani R; Lauro D; Ala A; Bussone R; Bisi G
Tumori; 2002; 88(3):S10-1. PubMed ID: 12365369
[TBL] [Abstract][Full Text] [Related]
38. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: a comprehensive review of variations in performance and technique.
Newman LA
J Am Coll Surg; 2004 Nov; 199(5):804-16. PubMed ID: 15501123
[No Abstract] [Full Text] [Related]
40. A new radiocolloid for sentinel node detection in breast cancer.
Hodgson N; Zabel P; Mattar AG; Engel CJ; Girvan D; Holliday R
Ann Surg Oncol; 2001 Mar; 8(2):133-7. PubMed ID: 11258777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
